ISCF HDRUK DIH Sprint Exemplar: Using Routine NHS Data to Accelerate Clinical Trial Recruitment
Lead Research Organisation:
University of Oxford
Department Name: UNLISTED
Abstract
Every NHS hospital keeps a detailed record of activities both for the purposes of individual patient care and to ensure that the hospital is properly paid for the work that it does. A monthly report of activity, described in terms of ‘hospital episodes’ is sent to NHS Digital, who host the data in trust for the nation. Large-scale, randomised clinical trials allow us to establish whether or not a particular treatment works and whether it is safe. This knowledge is invaluable: without it, hospitals might be reluctant to adopt some new, life-saving innovation, or a new, more effective medicine might remain unproven and unused. However, clinical trials can be very expensive to conduct and many fail to recruit sufficient numbers of patients to allow them to provide a conclusive answer in a timely fashion.
This project will develop a system that uses the ‘hospital episodes’ information to identify potentially suitable patients from across the country so that they could be asked if they wished to take part in clinical trials. Previous studies have demonstrated that such an approach can be very successful in recruiting large numbers of patient volunteers to join major clinical research studies.
This project will develop a system that uses the ‘hospital episodes’ information to identify potentially suitable patients from across the country so that they could be asked if they wished to take part in clinical trials. Previous studies have demonstrated that such an approach can be very successful in recruiting large numbers of patient volunteers to join major clinical research studies.
Technical Summary
This project will deliver a secure, web-based service that uses data assets managed by NHS Digital to facilitate recruitment into large clinical trials and other research projects. There will be two components:
a) A metadata catalogue to facilitate use of HES data adapted from the NIHR Oxford Biomedical Research Centre catalogue toolkit. This will support annotation and
computable representation of source data, trial eligibility criteria, and data extraction requests.
b) A web-enabled system to facilitate clinical trial recruitment based on the NWEH FARSITE system originally designed for primary care. This will allow authorised
users to configure eligibility selection criteria (e.g. age-range, diagnosis), filter search results (e.g. by hospital), and generate lists of eligible individuals.
The work will be co-designed by experts in clinical trial design, data engineering, information governance, and NHS Digital systems and data assets. The work will be
evaluated using contemporary and hypothetical trial protocols, and demonstrated to potential users, including industry representatives. The project is time-limited but will inform the design and implementation of future systems to facilitate data-enabled clinical trials, prospective cohorts, and precision medicine studies. It will also provide an important component for an upgraded NIHR Health Data Finder.
a) A metadata catalogue to facilitate use of HES data adapted from the NIHR Oxford Biomedical Research Centre catalogue toolkit. This will support annotation and
computable representation of source data, trial eligibility criteria, and data extraction requests.
b) A web-enabled system to facilitate clinical trial recruitment based on the NWEH FARSITE system originally designed for primary care. This will allow authorised
users to configure eligibility selection criteria (e.g. age-range, diagnosis), filter search results (e.g. by hospital), and generate lists of eligible individuals.
The work will be co-designed by experts in clinical trial design, data engineering, information governance, and NHS Digital systems and data assets. The work will be
evaluated using contemporary and hypothetical trial protocols, and demonstrated to potential users, including industry representatives. The project is time-limited but will inform the design and implementation of future systems to facilitate data-enabled clinical trials, prospective cohorts, and precision medicine studies. It will also provide an important component for an upgraded NIHR Health Data Finder.
Organisations
- University of Oxford (Lead Research Organisation)
- NHS DIGITAL (Collaboration)
- African Academy of Sciences (Collaboration)
- Wellcome Trust (Collaboration)
- Bill & Melinda Gates Foundation (Collaboration)
- Centers for Disease Control and Prevention (CDC) (Collaboration)
- Medical Research Council (MRC) (Collaboration)
People |
ORCID iD |
Martin Landray (Principal Investigator) | |
Jim Davies (Co-Investigator) |
Publications
Collins R
(2020)
Randomization versus Real-World Evidence. Reply.
in The New England journal of medicine
Fraser AG
(2020)
Regulating drugs, medical devices, and diagnostic tests in the European Union: early lessons from the COVID-19 pandemic?
in European heart journal
Mafham M
(2020)
COVID-19 pandemic and admission rates for and management of acute coronary syndromes in England
in The Lancet
Morris EJA
(2021)
Impact of the COVID-19 pandemic on the detection and management of colorectal cancer in England: a population-based study.
in The lancet. Gastroenterology & hepatology
RECOVERY Collaborative Group
(2021)
Dexamethasone in Hospitalized Patients with Covid-19.
in The New England journal of medicine
RECOVERY Collaborative Group
(2020)
Lopinavir-ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
in Lancet (London, England)
Description | Interviewed for Lord O'Shaughnessy report into the future of commercial clinical trials |
Geographic Reach | Multiple continents/international |
Policy Influence Type | Contribution to new or improved professional practice |
Description | MHRA UK Clinical Trials legislation working group |
Geographic Reach | National |
Policy Influence Type | Participation in a guidance/advisory committee |
Description | Chair, NHS DigiTrials Board |
Organisation | NHS Digital |
Country | United Kingdom |
Sector | Public |
PI Contribution | Technical co-development of conformed data layer and services layer. Coordination of Patient & Public Involvement and Engagement, including PPI members on the Board, Co-development Panel, public engagement meetings (Sophia has details), Use cases for ascertainment of clinical outcomes and for mailing 13,000 participants with information about trial results applied to RECOVERY trial. |
Collaborator Contribution | Invitation services piloted for UK vaccine trials and the PRINCIPLE trial Microsoft and IBM partners contributed technical and service design expertise. |
Impact | Feasibility service (beta release); support for the RECOVERY trial including information on study outcomes to support 6 key findings that have impacted NHS and global treatment policies for COVID-19 (dexamethasone & tocilizumab save lives; hydroxychloroquine, lopinavir, azithromycin, convalescent plasma, colchicine are ineffective). |
Start Year | 2019 |
Description | Global Hearts Initiative: Expanding the Evidence Base for Cardiovascular Disease Risk Factors |
Organisation | Centers for Disease Control and Prevention (CDC) |
Country | United States |
Sector | Public |
PI Contribution | Collaboration with Global Non-Communicable Disease Branch of the US Center of Disease Control. Funding from CDC-Foundation. Title 'Global Hearts Initiative: Expanding the Evidence Base for Cardiovascular Disease Risk Factors'. There is a formal agreement in place. |
Collaborator Contribution | academic partnership |
Impact | n/a |
Start Year | 2019 |
Description | Good Clinical Trials Initiative |
Organisation | African Academy of Sciences |
Country | Kenya |
Sector | Charity/Non Profit |
PI Contribution | Development of new guidelines for randomised controlled trials (ongoing) |
Collaborator Contribution | Widespread, cross-sector, national and international engagement (including pharma, academia, WHO, FDA, EMA, MHRA, ICH, AMS, NIHR, UKRI, G7, and patient advocacy organisations) |
Impact | consultation meetings held; draft guidelines under development |
Start Year | 2019 |
Description | Good Clinical Trials Initiative |
Organisation | Bill and Melinda Gates Foundation |
Country | United States |
Sector | Charity/Non Profit |
PI Contribution | Development of new guidelines for randomised controlled trials (ongoing) |
Collaborator Contribution | Widespread, cross-sector, national and international engagement (including pharma, academia, WHO, FDA, EMA, MHRA, ICH, AMS, NIHR, UKRI, G7, and patient advocacy organisations) |
Impact | consultation meetings held; draft guidelines under development |
Start Year | 2019 |
Description | Good Clinical Trials Initiative |
Organisation | Wellcome Trust |
Country | United Kingdom |
Sector | Charity/Non Profit |
PI Contribution | Development of new guidelines for randomised controlled trials (ongoing) |
Collaborator Contribution | Widespread, cross-sector, national and international engagement (including pharma, academia, WHO, FDA, EMA, MHRA, ICH, AMS, NIHR, UKRI, G7, and patient advocacy organisations) |
Impact | consultation meetings held; draft guidelines under development |
Start Year | 2019 |
Description | RECOVERY Trial |
Organisation | Medical Research Council (MRC) |
Country | United Kingdom |
Sector | Public |
PI Contribution | Co-chief investigator Trial design, coordination, and delivery, including patient & public engagement, extensive media activities, use of routine data (from NHS DigiTrials and other NHS organisations), policy implications (with Rapid C19 group, DHSC, NHS, and internationally with FDA, EMA, WHO, NIH), and education 177 NHS hospitals + NHS DigiTrials + NHS Blood Transfusion |
Collaborator Contribution | MRC - financial. NHS Trusts - Incorporated the trial daily working practices for COVID-19 care; administered treatments as part of the trial |
Impact | 10 key findings (4 since last year) that have impacted NHS and global treatment policies for COVID-19 (dexamethasone, tocilizumab, casirivimab+imdevimab, baricitinib save lives; hydroxychloroquine, lopinavir, azithromycin, convalescent plasma, colchicine and aspirin do not). Use of dexamethasone, tocilizumab, casirivimab+imdevimab were adopted into NHS, NIH and WHO treatment guidelines. |
Start Year | 2020 |
Description | 2023 Spring Lecture, North Staffordshire Medical Institute |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | Regional |
Primary Audience | Professional Practitioners |
Results and Impact | A masterclass on 'Smarter randomised trials for better pubic health'. The feedback received was all positive and the comments from the non-scientists were equally effusive |
Year(s) Of Engagement Activity | 2023 |
URL | https://nsmedicalinstitute.co.uk/2023/01/10/2023-spring-wade-lecture/ |
Description | Activity for the RECOVERY Trial |
Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Media (as a channel to the public) |
Results and Impact | During the RECOVERY Trial, which investigates the efficacy of COVID treatments for hospitalized patients, trial investigators took part in media interviews on multiple occasions with media organisations across the world. This resulted in televised interviews, thousands of printed and digital media articles that have showcased this importance of this trial worldwide. |
Year(s) Of Engagement Activity | 2020,2021,2022 |
Description | Founders Day Speech, Burford School, Oxfordshire |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Schools |
Results and Impact | Founders Day Speech, Burford School, Oxfordshire |
Year(s) Of Engagement Activity | 2023 |
Description | Inside Health |
Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Media (as a channel to the public) |
Results and Impact | RECOVERY Trial featured on BBC R4's Inside Health in April 2021 |
Year(s) Of Engagement Activity | 2021 |
Description | Lecture for Research4Gloucestershire, Gloucester |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Professional Practitioners |
Results and Impact | Lecture on "The road to RECOVERY: finding treatments in a crisis" for a Research4Gloucestershire session at Oxstalls Teaching Centre, Gloucester, for an audience drawn from primary and secondary care, medical and allied health professionals |
Year(s) Of Engagement Activity | 2023 |
Description | Lecture for West Biddlesex GP Vocational Training Scheme |
Form Of Engagement Activity | A formal working group, expert panel or dialogue |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Professional Practitioners |
Results and Impact | Lecture for West Biddlesex GP Vocational Training Scheme |
Year(s) Of Engagement Activity | 2023 |
Description | Lecture to Friends of St Mary's Church, Bampton |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Public/other audiences |
Results and Impact | Lecture to Friends of St Mary's Church, Bampton |
Year(s) Of Engagement Activity | 2022 |
Description | Lecture to Nottingham BRC |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | Regional |
Primary Audience | Professional Practitioners |
Results and Impact | Lecture to Nottingham BRC |
Year(s) Of Engagement Activity | 2022 |
Description | Lecture to York & Scarborough NHS Trust |
Form Of Engagement Activity | A formal working group, expert panel or dialogue |
Part Of Official Scheme? | No |
Geographic Reach | Regional |
Primary Audience | Professional Practitioners |
Results and Impact | 21 Nov 2022 - Lecture to York & Scarborough NHS Trust |
Year(s) Of Engagement Activity | 2022 |
Description | Lecture, Cardiff Scientific Society |
Form Of Engagement Activity | A formal working group, expert panel or dialogue |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Professional Practitioners |
Results and Impact | Lecture, Cardiff Scientific Society |
Year(s) Of Engagement Activity | 2023 |
Description | Lecture, Mid Yorkshire Teaching NHS Trust Working Together in Research event |
Form Of Engagement Activity | A formal working group, expert panel or dialogue |
Part Of Official Scheme? | No |
Geographic Reach | Regional |
Primary Audience | Professional Practitioners |
Results and Impact | Lecture, Mid Yorkshire Teaching NHS Trust Working Together in Research event |
Year(s) Of Engagement Activity | 2023 |
Description | Lecture, RAF Brize Norton, Oxfordshire |
Form Of Engagement Activity | A formal working group, expert panel or dialogue |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Public/other audiences |
Results and Impact | Lecture, RAF Brize Norton, Oxfordshire |
Year(s) Of Engagement Activity | 2023 |
Description | Lecture/public meeting, Amey Hall, Abingdon School, Oxfordshire |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Public/other audiences |
Results and Impact | Lecture/public meeting, Amey Hall, Abingdon School, Oxfordshire |
Year(s) Of Engagement Activity | 2022 |
Description | Lecture/talk for West Middlesex GP Vocational Training Scheme |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Professional Practitioners |
Results and Impact | A 40-45 minute talk titled 'Clinical trials in a crisis - putting the evidence in evidence based medicine' with 15-20 minutes Q&A for 40-50 GP trainees st1-3, some of whom were also engaged in fellowships, PhD studies and research. |
Year(s) Of Engagement Activity | 2023 |
Description | Making Clinical Trials easier |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Public/other audiences |
Results and Impact | Type of event - Magazine-style - an online mix of discussion, film and quiz X3 Number of attendees - 35 per event Primary audience - members of the public: adults in England Title - Making Clinical Trials Easier |
Year(s) Of Engagement Activity | 2020 |
Description | NHS Digitrials public panel |
Form Of Engagement Activity | A formal working group, expert panel or dialogue |
Part Of Official Scheme? | No |
Geographic Reach | Regional |
Primary Audience | Public/other audiences |
Results and Impact | 'What are clinical trials? presented as part of the NHS Digitrials public panel |
Year(s) Of Engagement Activity | 2020 |
Description | Plenary Lecture to British Thoracic Society |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Professional Practitioners |
Results and Impact | Plenary Lecture to British Thoracic Society |
Year(s) Of Engagement Activity | 2023 |
Description | Plenary Lecture to World Congress of Pharmacology |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Professional Practitioners |
Results and Impact | Plenary Lecture to World Congress of Pharmacology |
Year(s) Of Engagement Activity | 2023 |
Description | Profile in The Lancet |
Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Media (as a channel to the public) |
Results and Impact | March 2022 - Profile in The Lancet |
Year(s) Of Engagement Activity | 2022 |
URL | https://www.thelancet.com/pdfs/journals/lancet/PIIS0140-6736(22)00527-X.pdf |
Description | Research4Gloucestershire |
Form Of Engagement Activity | A formal working group, expert panel or dialogue |
Part Of Official Scheme? | No |
Geographic Reach | Regional |
Primary Audience | Professional Practitioners |
Results and Impact | Lecture, Research4Gloucestershire, Gloucester |
Year(s) Of Engagement Activity | 2024 |
Description | Spring Lecture, North Staffordshire Medical Institute |
Form Of Engagement Activity | A formal working group, expert panel or dialogue |
Part Of Official Scheme? | No |
Geographic Reach | Regional |
Primary Audience | Professional Practitioners |
Results and Impact | Spring Lecture, North Staffordshire Medical Institute |
Year(s) Of Engagement Activity | 2024 |
Description | The Life Scientific |
Form Of Engagement Activity | A broadcast e.g. TV/radio/film/podcast (other than news/press) |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Media (as a channel to the public) |
Results and Impact | Subject of an episode of BBC Radio 4's The Life Scientific. Aired June 2022 |
Year(s) Of Engagement Activity | 2022 |